Pharmaceuticals · Key players

Top Breast Cancer Therapeutics companies

The 6 key players our Breast Cancer Therapeutics report profiles, and other companies free public records show in this market.

Key players in Breast Cancer Therapeutics

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Breast Cancer Therapeutics market
#CompanyWebsiteOur reports
1 Roche roche.com (opens in a new tab) 1,485 reports
2 Pfizer Inc. pfizer.com (opens in a new tab) 2,310 reports
3 Novartis AG novartis.com (opens in a new tab) 1,551 reports
4 AstraZeneca astrazeneca.com (opens in a new tab) 957 reports
5 Eli Lilly and Company lilly.com (opens in a new tab) 1,056 reports
6 Daiichi Sankyo Company daiichisankyo.com (opens in a new tab) 165 reports

Also active in Breast Cancer Therapeutics

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Breast Cancer Therapeutics, from free public records
CompanyWhere public records show them
Hikma Pharmaceuticals PLC
Mylan N.V.
Eugia Pharma
Fresenius SE & CO
Sichuan Baili Pharmaceutical Co., Ltd.
Jiangsu HengRui Medicine Co., Ltd.
Teva Pharmaceutical
Accord Healthcare
Merck & Co., Inc.
Gland
Dr Reddy’s Laboratories
Shanghai Henlius Biotech

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.

Top trial sponsors in Breast Cancer Therapeutics

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. AstraZeneca 36 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Novartis AG 21 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Roche 18 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Pfizer Inc. 14 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Sichuan Baili Pharmaceutical Co., Ltd. 12 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Eli Lilly and Company 11 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Jiangsu HengRui Medicine Co., Ltd. 8 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Merck & Co., Inc. 8 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Breast Cancer Therapeutics reports by place

One report for each place. Each tile opens that place's report.

Regions 7

World report Africa report APAC report Europe report Latin America report Middle East report North America report

Countries 26

Australia report Brazil report Canada report China report Ecuador report Egypt report France report Germany report Hong Kong report India report Italy report Japan report Kenya report Malaysia report Mexico report New Zealand report Philippines report Russia report Saudi Arabia report Singapore report South Africa report Spain report Thailand report UAE report UK report US report

Compare all 33 places for Breast Cancer Therapeutics, with active trials

Get the full Breast Cancer Therapeutics report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.